Year Three "Ethics"

Riverside Research Ethics Committee application form, patient information, serious adverse events summary, ethics committee end of study report, correspondence, ethics committee protocol amendments and ethics approval.

File also contains adverse events papers and safety reporting letters relating to additional study protocols where infliximab was used.

2002-2004

1 file (in 2 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2060.